BC Week In Review | Dec 1, 2017
Financial News

Step Pharma adds €8.6M to series A

Autoimmune play Step Pharma S.A.S. (Paris, France) raised €8.6 million ($10.2 million) in the second and final close of a series A round, bringing the total to €14.5 million ($17.1 million). New investor Pontifax Group...
BC Extra | Nov 21, 2017
Financial News

Step Pharma adds €8.6M to series A

Autoimmune play Step Pharma S.A.S. (Paris, France) raised €8.6 million ($10.2 million) in the second and final close of a series A round, bringing the total to €14.5 million ($17.1 million). New investor Pontifax Group...
BC Innovations | May 25, 2017
Finance

Europe’s translational springtime

European science is showing early signs of translational growth, with VCs increasingly shifting their focus to preclinical assets. But investors are concerned the region still doesn’t have the supply of management talent or funding it...
BC Innovations | Feb 16, 2017
Emerging Company Profile

Autoimmunity alternative

Inhibiting the nucleotide biosynthetic pathway in autoimmune diseases is one way to avoid the risks of broad immunosuppression, but the marketed compounds have serious side effects of their own. Step Pharma is pursuing a safer...
BC Innovations | Jan 19, 2017
Finance

Kurma chameleon

French life science VC Kurma Partners S.A. is experimenting with a new investment model to accelerate the transfer of European academic research into the commercial setting with less risk than standard seed investments. The firm...
Items per page:
1 - 5 of 5